Literature DB >> 12228775

Utilization and outcomes of the implantable cardioverter defibrillator, 1987 to 1995.

Mark A Hlatky1, Olga Saynina, Kathryn M McDonald, Alan M Garber, Mark B McClellan.   

Abstract

BACKGROUND: The patterns of adoption of the implantable cardioverter defibrillator (ICD) and the outcomes of its use have not been well documented in general, unselected populations. The purpose of this study was to document the impact of the ICD in widespread clinical practice.
METHODS: We identified ICD recipients by use of the hospital discharge databases of Medicare beneficiaries for 1987 through 1995 and of California residents for 1991 through 1995. The index admission for each patient was linked to previous and subsequent admissions and to mortality files to create a longitudinal patient profile.
RESULTS: The rate of ICD implantations increased >10-fold between 1987 and 1995, as both the number of hospitals performing the procedure and the volume of ICD implantations per hospital rose. Mortality rates within 30 days of ICD implantation decreased from 6.0% to 1.9%, and mortality rates within 1 year fell from 19.3% to 11.4%. Surgical interventions to revise or replace the ICD within the first year remained about 5%, however, and cumulative expenditures at 1 year ($46,000-$51,000) changed very little. ICD implantation rates varied >3-fold among different regions of the United States.
CONCLUSIONS: ICD use has expanded markedly during the study period, with improved mortality rates, but medical expenditures and rates of surgical revision remain high for ICD recipients.

Entities:  

Mesh:

Year:  2002        PMID: 12228775     DOI: 10.1067/mhj.2002.125496

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

1.  Volume, outcome, and policy.

Authors:  Mark A Hlatky
Journal:  J Interv Card Electrophysiol       Date:  2012-12-18       Impact factor: 1.900

2.  Efficacy and safety of ICD therapy in a population of elderly patients treated with optimal background medication.

Authors:  Gabor Duray; Sergio Richter; Johannes Manegold; Carsten W Israel; Gerian Grönefeld; Stefan H Hohnloser
Journal:  J Interv Card Electrophysiol       Date:  2006-01-18       Impact factor: 1.900

3.  Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillators.

Authors:  Joseph S Ross; Jonathan Bates; Craig S Parzynski; Joseph G Akar; Jeptha P Curtis; Nihar R Desai; James V Freeman; Ginger M Gamble; Richard Kuntz; Shu-Xia Li; Danica Marinac-Dabic; Frederick A Masoudi; Sharon-Lise T Normand; Isuru Ranasinghe; Richard E Shaw; Harlan M Krumholz
Journal:  Med Devices (Auckl)       Date:  2017-08-16

4.  Racial disparity and technology diffusion: the case of cardioverter defibrillator implants, 1996-2001.

Authors:  Ava Stanley; Derek DeLia; Joel C Cantor
Journal:  J Natl Med Assoc       Date:  2007-03       Impact factor: 1.798

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.